DVAX - Dynavax Technologies Corporation
| Previous Close | 10.54 |
| Open | 10.59 |
| Bid | 11.10 x 4000 |
| Ask | 11.28 x 1400 |
| Day's Range | 10.53 - 11.27 |
| 52 Week Range | 7.85 - 22.80 |
| Volume | 1,758,058 |
| Avg. Volume | 908,172 |
| Market Cap | 697.756M |
| Beta (3Y Monthly) | 1.32 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.36 |
| Earnings Date | Feb 26, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 31.00 |
- GlobeNewswire•6 days ago
Dynavax Technologies to Report Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on February 26
BERKELEY, Calif., Feb. 12, 2019 -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and developing novel.
- GlobeNewswire•7 days ago
Recent Analysis Shows Corcept Therapeutics, CDK Global, Dynavax Technologies, ICU Medical, American Vanguard, and Cabot Market Influences — Renewed Outlook, Key Drivers of Growth
NEW YORK, Feb. 11, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
- Motley Fool•8 days ago
Why Dynavax Technologies Stock Marched Higher in January
Dynavax's stock did a U-turn in January. Here's why.
- GlobeNewswire•20 days ago
Heather Rowe Named Dynavax’s Vice President of Investor Relations and Corporate Communications
BERKELEY, Calif., Jan. 29, 2019 -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and developing novel.
- ACCESSWIRE•last month
Today's Research Reports on Trending Tickers: Dynavax Technologies and Tyme Technologies
NEW YORK, NY / ACCESSWIRE / January 16, 2019 /U.S. markets rose on Tuesday as Netflix helped push the tech sector higher after announcing it would raise the price of its monthly membership. Tech giants ...
- Motley Fool•last month
Why Dynavax Technologies Stock Fell 51% in 2018
Dynavax had a terrible 2018. Here's why.
- Simply Wall St.•last month
Is Dynavax Technologies Corporation (NASDAQ:DVAX) Worth US$10.80 Based On Intrinsic Value?
How far off is Dynavax Technologies Corporation (NASDAQ:DVAX) from its intrinsic value? Using the most recent financial data, I am going to take a look at whether the stock is Read More...
- TheStreet.com•last month
2 Small-Caps That Should Continue to Stage Comebacks in 2019
After a brutal fourth quarter to close out 2018, equities have started out on the right foot so far in 2019. Some soothing words from the Federal Reserve have helped the action in recent trading sessions, as has some progress on the trade talks between China and the United States. Helping tremendously are rallies in beaten-down sectors within the market.
- GlobeNewswire•last month
Sam’s Club and Dynavax Technologies Corporation Announce Collaboration to Make HEPLISAV-B® Available to Sam’s Club Patients
Dynavax Technologies Corporation (DVAX), a leader in developing immunotherapies based on toll-like receptor (TLR) biology, and Sam’s Club, a leading membership warehouse club offering superior products, savings and services to millions of members in nearly 600 clubs, have teamed up to introduce HEPLISAV-B into Sam’s Club retail pharmacies nation-wide where pharmacists can immunize patients. HEPLISAV-B is indicated for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. This is the first new hepatitis B vaccine in the United States in more than 25 years, and the only two-dose, one-month hepatitis B vaccine for adults.
- Motley Fool•last month
Here's Why Dynavax Technologies Slid 19% in December
Investors worried disappointing vaccine sales won't improve in 2019 sent the stock tumbling.
- GlobeNewswire•2 months ago
Dynavax to Present at 37th Annual J.P. Morgan Healthcare Conference
BERKELEY, Calif., Jan. 03, 2019 -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and developing novel.
- Benzinga•2 months ago
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
After extended weakness, biotech stocks turned a corner along with the broader markets to close out the week. With just a session left, it looks less likely the sector ends in the black for the year. The ...
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of DVAX earnings conference call or presentation 5-Nov-18 9:30pm GMT
Q3 2018 Dynavax Technologies Corp Earnings Call
- Insider Monkey•2 months ago
Is Dynavax Technologies Corporation (DVAX) Going to Burn These Hedge Funds?
There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating the market further by examining what famous hedge fund operators such as Carl Icahn and George Soros think. Those hedge fund operators make billions of dollars each […]
- Motley Fool•3 months ago
Why Dynavax Technologies Corporation Fell 20.2% in October
Preliminary data that looked good on the surface left investors with more questions than answers.
- Associated Press•3 months ago
Dynavax Technologies: 3Q Earnings Snapshot
The Berkeley, California-based company said it had a loss of 65 cents per share. The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
- Motley Fool•3 months ago
Don't Waste Your Money on Penny Stocks; These 3 Stocks Are Better Buys
If you're looking for high-reward stocks, these three could pay off big.
- Zacks•4 months ago
Dynavax Technologies (DVAX) Q3 Earnings Preview: What to Watch Ahead of the Release
Dynavax Technologies (DVAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks•4 months ago
Dynavax (DVAX) Catches Eye: Stock Jumps 9.8%
Dynavax (DVAX) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Motley Fool•4 months agoWhy American Railcar Industries, PetMed Express, and Dynavax Technologies Jumped Today
Find out which of these companies got a buyout bid.
- Motley Fool•4 months ago
Why Dynavax Technologies Corporation Is Surging Today
Encouraging clinical data helps the beaten-down biotech to recover.
